openPR Logo
Press release

CNV (Choroidal NeoVascularization) Market - Key Trends and Forecast Research Report 2023

02-07-2018 09:20 AM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
CNV (Choroidal NeoVascularization) Market - Key Trends

Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or due to Age-related Macular Degeneration (AMD). This results in fluid accumulation below the retinal pigment epithelium, which can lead to vision loss or extreme myopic vision among individuals. CNV is also seen in individuals with diabetic retinopathy. In rare cases, it can occur among individuals with defects in Bruch's membrane, the innermost layer of the choroid. It has also been observed by the American Academy of Ophthalmology and other reports that patients with CNV in one eye have a very high probability to contract CNV in the other eye within a short frame of time. According to the British Journal of Ophthalmology published in 2007, age?related macular degeneration (AMD) is one of the leading causes of irreversible sight loss among adults registered as legally blind. Among these, two-thirds of people with AMD have the wet form, which can progress quickly causing irreversible sight loss within days or weeks. In 2007, approximately 250,000 people were suffering from neovascular AMD in the U.K, with an incidence rate of 25,000 and 30,000 new cases annually. 

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8194
The only successful treatment option that is available commercially in the market for CNVs include intravitreal (direct to the eye) injections of anti-VEGF drugs to control the neovascularization and reduce the fluid accumulated. The most common anti-VGEF compounds are Ranibizumab (Trade name: Lucentis), Bevacizumab (Trade name: Avastin) and the novel drug Pegaptanib (Trade name: Macugen). These drugs belong to a class called anti-angiogenic drugs, their primary objective being the inhibition of the growth of new blood vessels. Anti angiogenic drugs are more commonly used for cancer treatment, where cancerous cells promote angiogenesis resulting in the proliferation of cells in large numbers, thus forming tumors. Bevacizumab is a successfully used cost effective drug for the treatment of cancer as well as AMD related CNVs with a very high half life (more than twice) in comparison with Ranibizumab. However chances of adverse effects with Bevacizumab are comparatively higher, hence Ranibizumab (Lucentis) is now currently the most effectively and safely used treatment for CNV. Pegaptanib on the other hand is in Phase IV of the clinical trials wherein only 1000 patients so far have been treated with significant success rate. 

With increasing aging population throughout the world the probability of occurrence of wet-AMD is high, especially in China and Japan where the aging population is predicted to tip over the young adult population. The patents for both Bevacizumab and Ranibizumab are till 2018 hence after patent expiry it is predicted that their sales shall significantly increase, especially with the entrance of Asian drug manufacturers. 

Get Discount on Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8194
Currently the companies that manufacture Ranibizumab are Novartis (licensed) in global market and Genetech (patented) in the U.S. Bevacizumab too was developed by Roche Pharma in association with Genentech and is currently marketed by Roche internationally. Pegaptanib is manufactured by Eyetch Inc. and marketed by Pfizer Inc. 

Pegaptanib has been approved and is available only in North America, Europe, Brazil and Australia. Ranibizumab is available under the name Lucentis with high market share in Europe and North America and growing in Asia-Pacific region. Bevacizumab is sold as Avastin globally with highest growth rate observed in Asia and highest voluminous growth seen in the North Americas and European markets. 

Report Details @ https://www.transparencymarketresearch.com/choroidal-neovascularization-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CNV (Choroidal NeoVascularization) Market - Key Trends and Forecast Research Report 2023 here

News-ID: 934702 • Views: 144

More Releases from Transparency Market Research

Petroleum Dyes Market Analysis and Value Forecast Snapshot by End-use Industry 2 …
Introduction Petroleum dyes are materials that are used to add color to petroleum products, lubricating oils, and gasoline. These dyes are complex and unsaturated aromatic compounds that possess characteristics such as solubility, and intense color Markers are colorless ingredients that are added to fuels which can be perceived by adding precise reagent to add color. Commonly used petroleum dyes are azo dyes and alkyl dyes. Petroleum dyes are used to prevent
Tank Insulation Market Company Profiles, Financial Perspective, Top Technologies …
Tank insulation helps in covering of bulk storage tanks and jacketing to reduce heat loss or gain for large, flat-bottomed tank that store materials which are sensitive to temperature fluctuation Read Report Overview @ https://www.transparencymarketresearch.com/tank-insulation-market.html The source of heat for a boiler is combustion of any of the fuels such as wood, coal, oil, or natural gas. Tank insulation transfers the heat to water, which circulates through the radiators for heating purpose.
Silicon Nitride Balls Market 2027: Industry Demand, Growth, Analysis & Forecast
Silicon Nitride Balls Market: Overview Silicon nitride is a composition of nitrogen and silicon chemical elements. It is thermodynamically stable and is used in a wide range of applications. Silicon nitride balls are made from silicon nitride powder through a series of processes. They are commonly known as silicon nitride ceramic balls. Silicon nitride balls are gray or black in color and are primarily used in bearings. These balls are suitable
Post Recycled-fiber Market 2019 Research Report Analysis, Size, Share, Growth, T …
Post Recycled-fiber Market: Overview Post-consumer waste is referred to fibrous products that are discarded after their service life. Finished paper products such as paper, paperboard, corrugated boxes, old newspapers, old magazines, mixed waste paper, tabulating cards, used cordage, and fibrous wastes from retail stores, office buildings, and homes are commonly treated as post-consumer waste. Donated & discarded apparels, some plastic items such as plastic bottles made from polyethylene terephthalate, nylon from

All 5 Releases


More Releases for CNV

Choroidal Neovascularization (CNV) Market Set to Witness Y-o-Y Growth by 2021
Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related macular degeneration, glaucoma, cataract, bulging eyes, diabetic macular edema, ocular hypertension, retinal detachment, uveitis, and refractive errors. Choroidal neovascular membranes refer to the
CNV (Choroidal NeoVascularization) Market: Business Intelligence & Market Insigh …
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or
Global CNV (Choroidal NeoVascularization) Market - Industry Size, Share, Growth, …
Latest industry research report on: Global Choroidal NeoVascularization Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized
CNV (Choroidal NeoVascularization) Market Set to Surge Significantly by 2023
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or
Choroidal Neovascularization (CNV) Market Demand is Increasing in Most Part of W …
Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related macular degeneration, glaucoma, cataract, bulging eyes, diabetic macular edema, ocular hypertension, retinal detachment, uveitis, and refractive errors. Choroidal neovascular membranes refer to the
CNV (Choroidal NeoVascularization) Market Analysis Report and Industry Forecast …
Choroid is the part of eye that lies in between the retina (vision sensory area) and the sclera (the outer layer of the eye), this area consist of blood vessels that supply nutrients to the retinal part of our eye. Choroidal NeoVascularization (CNV) is a disease, which is characterized by the formation of new blood vessels that arise either due to the presence of Vascular Endothelial Growth Factors (VGEF) or